What is Harmony Biosciences Holdings, Inc.'s net income?

Harmony Biosciences Holdings, Inc. (HRMY) reported net income of $32.49M in Q1 2026.

How has Harmony Biosciences Holdings, Inc.'s net income changed year-over-year?

Harmony Biosciences Holdings, Inc.'s net income decreased by 28.7% year-over-year, from $45.56M to $32.49M.

What is the long-term trend for Harmony Biosciences Holdings, Inc.'s net income?

Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s net income has grown at a 46.3% compound annual growth rate (CAGR), from $34.6M to $158.69M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Harmony Biosciences Holdings, Inc. HRMY Net Income

Net Income at other companies

Jazz PharmaceuticalsJAZZ

$293.1M+417%

AlkermesALKS

-$66.48M-396%

Axsome TherapeuticsAXSM

-$64.54M-8.6%

Stoke Therapeutics, Inc.STOK

-$50M-144%

Amneal Pharmaceuticals, Inc.AMRX

$78M+217%

Acadia PharmaceuticalsACAD

$3.64M-80.8%

Segments

By segment

See full

Rare Neurological Diseases$32.49M-28.7%

Other financials

Income statement

See full

Revenue$215.4M+16.6%

Gross profit$170.9M+11.9%

Operating income$37.3M-33.7%

Net income$32.5M-28.7%

EPS (diluted)$0.55-29.5%

Balance sheet

See full

Cash & equivalents$589.4M+20.5%

Total debt$164.6M-7.2%

Total equity$910.3M+26.3%

Total assets$1.3B+20.5%

Cash flow

See full

Operating cash flow$27.8M-18.3%

CapEx$107.0K-79.1%

Free cash flow$126.0M+67.9%

Valuation

See full

Market cap$1.98B-14.9%

Enterprise value$1.55B-24.9%

P/E13.6×-1.6×

P/S2.2×-0.9×

Profitability

See full

Gross margin76.5%-1.8pp

Operating margin21.1%-5.1pp

Net margin16.2%-4.3pp

FCF margin40.1%+9.5pp

Returns & leverage

See full

Return on equity17.9%-6.9pp

Debt / equity0.2×-0.1×

Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s net income?: Harmony Biosciences Holdings, Inc. (HRMY) reported net income of $32.49M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s net income changed year-over-year?: Harmony Biosciences Holdings, Inc.'s net income decreased by 28.7% year-over-year, from $45.56M to $32.49M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s net income?: Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s net income has grown at a 46.3% compound annual growth rate (CAGR), from $34.6M to $158.69M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.